Immunotherapy Addition Demonstrates Sustained Survival Benefits in Long-Term Follow-Up of NRG Oncology Trial for Advanced or Recurrent Endometrial Cancer
In a groundbreaking advancement for the treatment of advanced and recurrent endometrial cancer, recent prolonged follow-up results from the NRG ...
